Morgan Stanley
CMND icon

Morgan Stanley’s Clearmind Medicine CMND Stock Holding History

Morgan Stanley’s Portfolio CMND Stock Details CMND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54K Buy
+700
New +$3.98K ﹤0.01% 7449
2025
Q4 		– Sell
-6
Closed -$2.63K – 8253
2025
Q3 		$2.63K Hold
6
– – ﹤0.01% 7251
2025
Q2 		$2.31K Hold
6
– – ﹤0.01% 7198
2025
Q1 		$2.65K Hold
6
– – ﹤0.01% 7116
2024
Q4 		$3.54K Buy
+6
New +$3.32K ﹤0.01% 7091
2023
Q1 		– Hold
0
– -$2.21K – 7732
2022
Q4 		– Hold
0
– – – 7348

Other funds holding CMND

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Morgan Stanley's CMND Position: Q2 2026 in Review

Morgan Stanley opened a new position in Clearmind Medicine (CMND) in Q2 2026: 700 shares worth $1.54K. The stake represents ﹤0.01% of the portfolio and ranks #7449 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in CMND as recently as Q3 2025.

Morgan Stanley first reported a position in CMND in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.54K in Q4 2024. 6 funds tracked by Wall St. Rank hold CMND as of Q2 2026.

  • Morgan Stanley held 700 shares of Clearmind Medicine worth $1.54K as of Q2 2026.
  • Clearmind Medicine was a new Morgan Stanley position in Q2 2026.
  • Clearmind Medicine made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7449 holding.
  • Morgan Stanley first reported a position in Clearmind Medicine in Q4 2024 and has held it in 5 quarters since.
  • Morgan Stanley's Clearmind Medicine position peaked at $3.54K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Clearmind Medicine as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.